Afuco™ Anti-IGHE ADCC Therapeutic Antibody (Ligelizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human IGHE.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-755 |
Pricing | Inquiry |
Host | Human |
Target | IGHE |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Applications | Neut, ELISA, IF, IP, FuncS, FC |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |